| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| HLA-A*0201 & B2M & Survivin (TLPPAWQPFL) | Biotinylated Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Complex Protein (Monomer, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug | |||
| HLA-A*0201 & B2M & Survivin (TLPPAWQPFL) | PE-Labeled Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Tetramer Protein | Human | HEK293 | $410.00 25ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| AFX-5931 | AFX-5931 | Phase 2 Clinical | Eczema | 상세 | |
| MW-151 | MW01-9-034WH; MW-151; MW01-2-151SRM | Phase 1 Clinical | University Of Kentucky | Drug-Related Side Effects and Adverse Reactions; Poisoning; Cognition Disorders | 상세 |
| 64CU-DOTA-ECL1i | Phase 1 Clinical | Washington University School Of Medicine | Carotid Artery Diseases; Heart Diseases; Arteriosclerosis | 상세 |
